AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
Autori principali: | , , , , , , , , |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Elsevier
2023-10-01
|
Serie: | IBRO Neuroscience Reports |
Accesso online: | http://www.sciencedirect.com/science/article/pii/S2667242123010126 |